Congratulations to Dr. Westphal (Scott Westphal) on receiving funding for a study evaluating the safety and efficacy of Tegoprubart in patients undergoing kidney transplantation!

I am appreciative of JDRF’s leadership, support and partnership in making the #T1D islet cell transplant Proof of Concept study using tegoprubart at @UniversityOfChicago possible.

Read more in JDRF’s blog: jdrf.org/blog/2024/05/1…

$ELDN Eledon Pharmaceuticals, Inc.

Biotech Stocks 9/25 @ Open 🔔

$RNAZ 165% Pre-clin data
$CLNN 12% HEALEY ALS data
$LTRN 4% 1st patient dosed
$ELDN 2% Tegoprubart 2nd transplant

$SNY 0% Japan approves ALTUVIIIO®
$ASND 0% Presentation at ESPE
$APLS 0% J-Code SYFOVRE®
$HLVX 0% Closing public offering
$REGN 0%

We are pleased to announce a new collaboration with Eledon Pharmaceuticals, Inc. through which we will gain access to Eledon’s anti-CD40L antibody candidate, tegoprubart, for use in our ongoing preclinical studies. Read more: globenewswire.com/news-release/2…

We are excited to present at SVB Securities Global Biopharma Conference on February 15, 2023, at 5:00 p.m. ET.
Register for the webcast here: bit.ly/40S1CiV

$ELDN #eledonpharma #transplant #kidneytransplant #ALS #tegoprubart #BESTOW

$TSLA $SPY $SONG Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection blog.tipranks.com/eledon-pharmac… $QQQ $AAPL $BTC

$ELDN Eledon Pharmaceuticals uses Tegoprubart in historic transplant of genetically modified pig kidney to human.

More Info: pryzm.ozmosi.com/product/21702 $XBI $IBB $XPH $PPH

La deuxième xénotransplantation cardiaque réalisée comme la première à l'UMMC
Un nouveau traitement anti-rejet est utilisé : le tegoprubart qui bloque le CD154, une protéine impliquée dans l'activation du système immunitaire.
drive.google.com/file/d/1YUYR40…

$ELDN Eledon Pharmaceuticals will share new data from a Phase 1b trial of Tegoprubart in kidney transplant patients at the American Transplant Congress.

More Info: pryzm.ozmosi.com/product/21702 $XBI $IBB $XPH $PPH

$ELDN Eledon reports advancements in using Tegoprubart to prevent transplant rejection in clinical trials.

More Info: pryzm.ozmosi.com/product/21702 $XBI $IBB $XPH $PPH

$ELDN Eledon Pharmaceuticals uses Tegoprubart anti-CD40L Antibody in second-ever pig-to-human heart transplant, involving genetically modified heart.

More Info: pryzm.ozmosi.com/product/21702 $XBI $IBB $XPH $PPH

📢 $ELDN - Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human

newsfilter.io/a/d9ac3884f8aa…

For Quick News, Spikes and Movers:
discord.gg/AMpTg3GTxP

$ELDN Eledon Pharmaceuticals reports enrollment of 12th participant in Phase 2 BESTOW Trial assessing Tegoprubart for preventing organ rejection.

More Info: pryzm.ozmosi.com/product/21702 $XBI $IBB $XPH $PPH

#tegoprubart #kidneytransplant mechanism of action

Eledon shares fresh data on Tegoprubart Phase 1b trial for Kidney Transplant Rejection Prevention.

More Info: pryzm.ozmosi.com/product/21702 $XBI $IBB $XPH $PPH

$ELDN Eledon Pharma to showcase data from Phase 1b trial of Tegoprubart for kidney transplant patients at 2023 American Society of Nephrology Kidney Week.

More Info: pryzm.ozmosi.com/product/21702 $XBI $IBB $XPH $PPH

We are proud of investigational tegoprubart’s role in this historic development in organ transplantation!

Excellent video on science of #xenotransplant from Leonardo V. Riella and Mass General Brigham Mass General Transplant.

#tegoprubart $ELDN Eledon Pharmaceuticals, Inc. eGenesis

Pleasure talking to BioSpace about $ELDN #antiCD40L #tegoprubart and the potential in #kidneytransplant and #xenotransplant

I am humbled, excited & grateful to the patient & our partners at MassGeneral Medicine & eGenesis for their trust in using #tegoprubart as part of the investigational regimen for today’s landmark pig-to-human #kidneytransplant .

I am also immensely proud of our $ELDN team in making